洲明科技(300232.SZ):林洺鋒累計減持55.2萬張洲明轉債
格隆匯1月10日丨洲明科技(300232.SZ)公佈,2020年1月10日,公司收到控股股東、實際控制人林洺鋒的通知,自2018年12月19日至2018年12月27日,林洺鋒通過深圳證券交易所交易系統集中競價交易方式減持其所持有的洲明轉債54.1964萬張;2020年1月10日,通過深圳證券交易所交易系統集中競價交易方式減持其所持有的洲明轉債1.0002萬張。
自2018年12月19日至2020年1月10日,林洺鋒合計減持的洲明轉債數量為55.1966萬張,累計減持數量佔洲明轉債發行總量的10.07%。減持後,林洺鋒不再持有洲明轉債。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.